earnings
confidence high
sentiment positive
materiality 0.65
Nuwellis Q2 net sales up 14% to $2.0M; gross margin 76% vs 56%; CEO appointed
Nuwellis, Inc.
2026-Q2 EPS
reported -$77.88
vs consensus -$0.69
▼ miss
(-11128.4%)
- Net sales $2.0M, +14% YoY; U.S. revenue +17%; H1 sales $4.4M, +20%.
- Gross margin improved to 76% from 56% on pricing, mix, contract manufacturing.
- Net loss $4.8M incl. $1.7M non-cash warrant expense; cash $3.9M at June 30.
- Raised ~$12.7M gross proceeds from June offering and July financing/warrant exercises.
- Appointed Mike McCormick CEO effective June 30; FDA pre-sub for Aquadex label to 5kg.